INTRALASE FS2
Report
- Report Number
- 3006695864-2018-00467
- Event Type
- Injury
- Date Received
- March 8, 2018
- Date of Event
- February 9, 2018
- Report Date
- April 9, 2018
- Manufacturer
- JOHNSON & JOHNSON SURGICAL VISION, INC
- Product Code
- HNO
- PMA / PMN Number
- K060372
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- PHYSICIAN
Narratives
ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC. HAS BEEN SUBMITTED.
A REVIEW OF THE RECORDS RELATED TO THE DEVICE THAT INCLUDED LABELING, MANUALS, TRENDING, AND RISK DOCUMENTATION WAS PERFORMED. THE TREND REVIEW SHOWS THAT THERE IS NO SIGNIFICANT CHANGE OVER HISTORICAL COMPLAINT LIMITS AND NO RECOGNIZABLE ADVERSE TREND. THE RISKS AND MITIGATIONS ASSOCIATED WITH THE COMPLAINT ISSUE ARE IDENTIFIED IN EXISTING RISK DOCUMENTS AND NO NEW RISKS WERE IDENTIFIED AS PART OF THIS INVESTIGATION. THERE WAS NO PRODUCT DEFICIENCY IDENTIFIED. ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC. HAS BEEN SUBMITTED.
THE SURGERY CENTER REPORTED THAT A LASER VISION CORRECTION PATIENT PRESENTED WITH DIFFUSE LAMELLAR KERATITIS (DLK) IN BOTH EYES (OU) AT THE 1-DAY POST-OPERATIVE EXAM. A BRIEF DESCRIPTION FROM THE SURGERY CENTER INDICATED THE PATIENT HAD TRACE DLK IN THE RIGHT EYE (OD) AND DLK STAGE 1+ IN THE LEFT EYE (OS). THE PATIENT¿S CHIEF COMPLAINT WAS OF DISCOMFORT MORE ON THE OS THAN THE OD. TOPICAL STEROID DOSAGE WAS INCREASED TO RESOLVE SYMPTOMS. BEST CORRECTED VISUAL ACUITY (BCVA) FROM (B)(6) 2018: RIGHT EYE PRE-OP 20/20 -2.50 X -1.50 X 111, LEFT EYE PRE-OP 20/20 -3.75 X -.75 X 75. THIS REPORT IS FOR THE FEMTO LASER. A SEPARATE REPORT WILL BE SUBMITTED FOR THE EXCIMER LASER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 167375 | INTRALASE FS2 | FEMTOSECOND LASER | HNO | JOHNSON & JOHNSON SURGICAL VISION, INC | 20003D |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 40 YR | Required Intervention |